Clinical Trial Update: Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 trial evaluating amisulpride augmentation therapy for clozapine-resistant schizophrenia, with the study status show…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Treatment-resistant Schizophrenia | Phase 4 | Status: COMPLETED